

In the Top 5% of 2126 Similar Sized Companies on Comparably
In the Top 5% of 221 Nearby Companies in Washington, DC
1st place versus 3 competitors rated on Comparably
Mr. Papa brings over 35 years of experience in the healthcare and pharmaceutical industry, having most recently served as Chief Executive Officer and Chairman at Bausch and Lomb Corporation (“Bausch and Lomb”) (NYSE: BLCO) a global eye health company. During his tenure, Papa successfully led the Company’s IPO in May 2022 to raise $630 million. Prior to his role at Bausch and Lomb, Papa was the Chief Executive Officer and Chairman of Bausch Health.
He previously served as the Chairman and CEO of Perrigo, a private-label over-the-counter pharmaceuticals manufacturer, and led the pharmaceutical and technologies services division at Cardinal Health, a healthcare services and distribution company. Before that, Papa held the role of President and Chief Operating Officer at Watson Pharmaceuticals and worked for 14 years at Novartis Pharmaceuticals in the U.S. and Switzerland.
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Emergent Biosolutions.
Based on 20 ratings, Joseph C. Papa ranks right above AbbVie's CEO, Richard Gonzalez.
Emergent Biosolutions' CEO is highly regarded by Male employees. Overall, the CEO score has remained stable over the last 90 days.
Emergent Biosolutions ranks in the Top 5% of other companies on Comparably with 1,001-5,000 Employees for CEO Rating Score.
Emergent Biosolutions ranks in the Top 5% of other companies in Washington, DC for CEO Rating Score.
